Literature DB >> 28686972

Peptide nucleic acids (PNAs): currently potential bactericidal agents.

Hanar Narenji1, Pourya Gholizadeh2, Mohammad Aghazadeh1, Mohammad Ahangarzadeh Rezaee3, Mohammad Asgharzadeh4, Hossein Samadi Kafil5.   

Abstract

In recent years, the emergence of ESBL-producing and multi-drug resistant bacteria have been increased and designing novel components is necessary for confrontation these bacteria. Peptide nucleic acids (PNAs) are one of the synthetic components that bind to single strand DNA and RNA. Applications of these components are wide while, and one of the important applications of these components is inhibition of gene expression and knock downing the target gene follow as inhibition of bacterial growth. For PNA targeting gene, peptide-PNAs (PPNA) activity cannot be occurred without sequence homology, at the same time, it has been affected by sequence-based specific target and dose-dependent-based manner. Choosing the conserved sequence in different bacterial genus can provide broad-spectrum antimicrobial activity. In this review article, we studied several research papers and extract PNA targeting genes that cause gene knock down and inhibition of bacterial growth. Some novel opportunities for advancement and the design ultra-narrow-spectrum antimicrobial drugs against multi-drug can be accessible by utilizing PNA against necessary genes of pathogens. These results open novel vision for therapeutic intervention. Future researches are required to evaluate the safety, toxicity and pharmacokinetics properties of PPNAs in order to be utilized in clinical treatment.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Bactericidal agent; Peptide nucleic acid

Mesh:

Substances:

Year:  2017        PMID: 28686972     DOI: 10.1016/j.biopha.2017.06.092

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

Review 1.  "Clicking" Gene Therapeutics: A Successful Union of Chemistry and Biomedicine for New Solutions.

Authors:  Kira Astakhova; Roslyn Ray; Maria Taskova; Jesper Uhd; Annika Carstens; Kevin Morris
Journal:  Mol Pharm       Date:  2018-02-26       Impact factor: 4.939

2.  Artificial Activation of Escherichia coli mazEF and hipBA Toxin-Antitoxin Systems by Antisense Peptide Nucleic Acids as an Antibacterial Strategy.

Authors:  Marcin Równicki; Tomasz Pieńko; Jakub Czarnecki; Monika Kolanowska; Dariusz Bartosik; Joanna Trylska
Journal:  Front Microbiol       Date:  2018-11-26       Impact factor: 5.640

Review 3.  Acinetobacter baumannii Efflux Pumps and Antibiotic Resistance.

Authors:  Seyyed Naser Abdi; Reza Ghotaslou; Khudaverdi Ganbarov; Ahmad Mobed; Asghar Tanomand; Mehdi Yousefi; Mohammad Asgharzadeh; Hossein Samadi Kafil
Journal:  Infect Drug Resist       Date:  2020-02-12       Impact factor: 4.003

4.  Inhibiting mutant KRAS G12D gene expression using novel peptide nucleic acid-based antisense: A potential new drug candidate for pancreatic cancer.

Authors:  Ayelet Shai; Evleen Galouk; Reem Miari; Hala Tareef; Marei Sammar; Mouhammad Zeidan; Anwar Rayan; Mizied Falah
Journal:  Oncol Lett       Date:  2022-02-21       Impact factor: 2.967

Review 5.  Emerging Non-Traditional Approaches to Combat Antibiotic Resistance.

Authors:  Aditya Narayan Konwar; Shabiha Nudrat Hazarika; Pranami Bharadwaj; Debajit Thakur
Journal:  Curr Microbiol       Date:  2022-09-25       Impact factor: 2.343

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.